New formats needed 
Clinical trial data released this year in a study of cisgender men, transgender men, transgender women, and nonbinary individuals who have sex with partners assigned male at birth showed that using lenacapavir results in a 96% 
‘In my view, it’s analogous to dispensing a new drug that you haven’t come across before. You understand the relevant information related to the drug from a safety and effectiveness point of view, you communicate with the patient regarding relevant counselling points, and you document relevant information.’
Pharmacists honoured at annual awards
Pharmacists in Queensland and Tasmania have been recognised for their contributions to the health of the community, with awards presented at two events at...
Verapamil for type 1 diabetes
Recent research has shed light on a potential new avenue to reduce insulin requirements for people with type 1 diabetes.
An estimated 1.2 million Australians...
Early elixirs – calomel
‘The doctor comes with free good will, but ne’er forgets his calomel’
The highly toxic ‘cure-all’ calomel is all but forgotten today, but it was...
Pharmacy services have expanded in parts of QLD, but what does...
The success of the Urinary Tract Infection Pharmacy Pilot – Queensland is a stepping stone towards wider pharmacist prescribing.
Risks and benefits of CAMs in aged care
What role do pharmacists play in supporting and counselling the ageing population in improving their health outcomes with relevant CAMs?
This question is a common...
Chronic lymphocytic leukaemia and the pharmacist
The management of chronic lymphocytic leukaemia has changed dramatically in the last decade with the introduction of novel oral immune-targeted therapies. There are increasing opportunities for pharmacists to contribute to the multidisciplinary care of patients with CLL to ensure medicine safety and best patient outcomes.
